Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-06-10 Sale |
2021-06-11 4:15 pm |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
23,009 | $51.38 | $1,182,106 | 586,924 (Direct) |
View |
| 2021-06-07 Sale |
2021-06-09 5:54 pm |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
18,746 | $50.1 | $939,261 | 1,017,175 (Direct) |
View |
| 2021-06-03 Sale |
2021-06-04 4:16 pm |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $46.87 | $468,695 | 227,155 (Direct) |
View |
| 2021-05-12 Sale |
2021-05-14 5:20 pm |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
8,245 | $50.05 | $412,677 | 613,679 (Direct) |
View |
| 2021-04-22 Sale |
2021-04-26 5:15 pm |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
14,407 | $40.23 | $579,619 | 1,077,590 (Direct) |
View |
| 2021-04-15 Sale |
2021-04-19 7:12 pm |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
5,593 | $40.26 | $225,159 | 1,027,540 (Direct) |
View |
| 2021-04-08 Sale |
2021-04-12 6:11 pm |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
48,000 | $33.62 | $1,613,563 | 1,163,702 (Direct) |
View |
| 2021-03-12 Sale |
2021-03-16 7:39 pm |
Kymera Therapeutics Inc. | KYMR | Booth Bruce Director |
229,350 | $56.5 | $12,958,275 | 7,998,317 (Indirect) |
View |
| 2021-03-12 Sale |
2021-03-16 7:37 pm |
Kymera Therapeutics Inc. | KYMR | ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates X LLC 10% Owner |
229,350 | $56.5 | $12,958,275 | 6,885,631 (Indirect Direct) |
View |
| 2021-03-11 Sale |
2021-03-15 9:12 pm |
Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer |
15,000 | $60.13 | $901,991 | 170,361 (Direct) |
View |
| 2021-03-11 Sale |
2021-03-15 9:08 pm |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $60.15 | $601,528 | 476,317 (Direct) |
View |
| 2021-03-08 Sale |
2021-03-08 8:01 pm |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $50.65 | $506,470 | 244,061 (Direct) |
View |
| 2021-03-03 Sale |
2021-03-05 5:26 pm |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
20,000 | $44.78 | $895,634 | 254,061 (Direct) |
View |
| 2021-02-22 Sale |
2021-02-24 6:44 pm |
Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer |
37,064 | $50.68 | $1,878,355 | 47,547 (Direct) |
View |
| 2021-02-17 Sale |
2021-02-19 7:27 pm |
Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer |
22,936 | $56.42 | $1,293,936 | 84,611 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-06-16 Option Award |
2021-06-17 4:44 pm |
N/A 2031-06-15 |
Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director |
20,063 | $0 | 20,063 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-17 4:43 pm |
N/A 2031-06-15 |
Kymera Therapeutics Inc. | KYMR | Hall Steven Edward Director |
20,063 | $0 | 20,063 (Direct) |
View |
| 2021-06-14 Exercise |
2021-06-14 5:57 pm |
N/A 2029-05-22 |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
40,000 | $0 | 548,623 (Direct) |
View |
| 2021-06-14 Exercise |
2021-06-14 5:57 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
40,000 | $2.08 | 548,623 (Direct) |
View |
| 2021-06-10 Exercise |
2021-06-11 4:15 pm |
N/A 2029-11-13 |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
23,009 | $0 | 586,924 (Direct) |
View |
| 2021-06-10 Exercise |
2021-06-11 4:15 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
23,009 | $2.08 | 586,924 (Direct) |
View |
| 2021-06-07 Exercise |
2021-06-09 5:54 pm |
N/A 2029-11-13 |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
18,746 | $0 | 1,017,175 (Direct) |
View |
| 2021-06-07 Exercise |
2021-06-09 5:54 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
18,746 | $2.08 | 1,017,175 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-04 4:16 pm |
N/A 2029-08-28 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $0 | 227,155 (Direct) |
View |
| 2021-06-03 Exercise |
2021-06-04 4:16 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $2.08 | 227,155 (Direct) |
View |
| 2021-05-19 Exercise |
2021-05-19 5:56 pm |
N/A 2029-05-22 |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
15,000 | $0 | 548,623 (Direct) |
View |
| 2021-05-19 Exercise |
2021-05-19 5:56 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
15,000 | $2.08 | 548,623 (Direct) |
View |
| 2021-05-18 Other |
2021-05-18 6:17 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Atlas Venture Fund X L.P. 10% Owner |
1,122,619 | $0 | 6,885,631 (Direct) |
View |
| 2021-05-12 Exercise |
2021-05-14 5:20 pm |
N/A 2029-11-13 |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
8,245 | $0 | 613,679 (Direct) |
View |
| 2021-05-12 Exercise |
2021-05-14 5:20 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
8,245 | $2.08 | 613,679 (Direct) |
View |
| 2021-04-22 Exercise |
2021-04-26 5:15 pm |
N/A 2029-11-13 |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
14,407 | $0 | 1,077,590 (Direct) |
View |
| 2021-04-22 Exercise |
2021-04-26 5:15 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
14,407 | $2.08 | 1,077,590 (Direct) |
View |
| 2021-04-15 Exercise |
2021-04-19 7:12 pm |
N/A 2029-11-13 |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
11,593 | $0 | 1,027,540 (Direct) |
View |
| 2021-04-15 Exercise |
2021-04-19 7:12 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
11,593 | $2.08 | 1,027,540 (Direct) |
View |
| 2021-04-13 Exercise |
2021-04-13 6:39 pm |
N/A 2029-05-22 |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
15,000 | $0 | 548,623 (Direct) |
View |
| 2021-04-13 Exercise |
2021-04-13 6:39 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
15,000 | $2.08 | 548,623 (Direct) |
View |
| 2021-04-13 Exercise |
2021-04-13 6:37 pm |
N/A 2029-08-28 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
7,000 | $0 | 236,899 (Direct) |
View |
| 2021-04-13 Exercise |
2021-04-13 6:37 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
7,000 | $2.08 | 236,899 (Direct) |
View |
| 2021-04-08 Exercise |
2021-04-12 6:11 pm |
N/A 2019-11-13 |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
48,000 | $0 | 1,163,702 (Direct) |
View |
| 2021-04-08 Exercise |
2021-04-12 6:11 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
48,000 | $2.08 | 1,163,702 (Direct) |
View |
| 2021-03-12 Option Award |
2021-03-16 5:22 pm |
N/A 2031-03-11 |
Kymera Therapeutics Inc. | KYMR | Ridloff Elena Director |
40,127 | $0 | 40,127 (Direct) |
View |
| 2021-03-11 Exercise |
2021-03-15 9:12 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer |
10,000 | $1.31 | 170,361 (Direct) |
View |
| 2021-03-11 Exercise |
2021-03-15 9:12 pm |
N/A 2028-10-31 |
Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer |
10,000 | $0 | 170,361 (Direct) |
View |
| 2021-03-11 Exercise |
2021-03-15 9:08 pm |
N/A 2030-08-19 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $0 | 476,317 (Direct) |
View |
| 2021-03-11 Exercise |
2021-03-15 9:08 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $2.08 | 476,317 (Direct) |
View |
| 2021-03-08 Exercise |
2021-03-08 8:01 pm |
N/A 2030-08-19 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $0 | 244,061 (Direct) |
View |
| 2021-03-08 Exercise |
2021-03-08 8:01 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $2.08 | 244,061 (Direct) |
View |
| 2021-03-03 Exercise |
2021-03-05 5:26 pm |
N/A 2030-08-19 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
20,000 | $0 | 254,061 (Direct) |
View |
| 2021-03-03 Exercise |
2021-03-05 5:26 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
20,000 | $2.08 | 254,061 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 4:57 pm |
N/A 2031-02-28 |
Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 4:54 pm |
N/A 2031-02-28 |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
375,000 | $0 | 375,000 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 4:52 pm |
N/A 2031-02-28 |
Kymera Therapeutics Inc. | KYMR | Chesworth Richard Chief Scientific Officer |
60,000 | $0 | 60,000 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 4:27 pm |
N/A 2031-02-28 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
140,000 | $0 | 140,000 (Direct) |
View |
| 2021-02-18 Other |
2021-02-22 4:58 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Atlas Venture Fund X L.P. 10% Owner |
1,063,351 | $0 | 7,948,982 (Direct) |
View |
| 2020-09-04 Option Award |
2020-09-09 4:51 pm |
N/A 2030-09-03 |
Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director |
40,127 | $0 | 40,127 (Direct) |
View |
| 2020-08-25 Conversion |
2020-08-27 4:12 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner |
2,489,058 | $0 | 959,211 (Direct) |
View |
| 2020-08-20 Option Award |
2020-08-25 6:48 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks |
40,127 | $0 | 221,208 (Indirect) |
View |
| 2020-08-21 Conversion |
2020-08-25 6:48 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks |
4,096,835 | $0 | 221,208 (Direct) |
View |
| 2020-08-21 Option Award |
2020-08-25 6:48 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks |
978,693 | $20 | 221,208 (Direct) |
View |
Ownership |
2020-08-25 6:39 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks |
0 | $0 | 1,578,804 (Direct) |
View |
| 2020-08-25 Conversion |
2020-08-25 6:36 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Alexandria Venture Investments LLC 10% Owner |
1,214,237 | $0 | 467,932 (Direct) |
View |
| 2020-08-25 Conversion |
2020-08-25 4:39 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Redmile Group LLC Green Jeremy 10% Owner |
4,231,400 | $0 | 1,630,660 (Indirect) |
View |
| 2020-08-25 Conversion |
2020-08-25 4:30 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Hall Steven Edward Director |
5,688,667 | $0 | 2,192,249 (Indirect) |
View |
| 2020-08-25 Conversion |
2020-08-25 4:30 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Atlas Venture Fund X L.P. Atlas Venture Associates X LLC ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC Atlas Venture Opportunity Fund I L.P. 10% Owner |
21,561,726 | $0 | 9,061,668 (Direct) |
View |
| 2020-08-25 Conversion |
2020-08-25 4:30 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Booth Bruce Director |
21,561,726 | $0 | 1,112,686 (Indirect) |
View |
| 2020-08-20 Option Award |
2020-08-21 6:31 pm |
N/A 2030-08-19 |
Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer |
48,942 | $0 | 48,942 (Direct) |
View |